Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
A glycolipid that specifically binds shigella toxin was isolated from both HeLa cells and rabbit jejunal mucosa and identified as globotriaosylceramide (Gb3) by its identical mobility on HPTLC to authentic erythrocyte Gb3. Toxin also bound to a band tentatively identified as alpha-hydroxylated Gb3. In addition, toxin bound to P1 antigen present in group B human erythrocyte glycolipid extracts. The common feature of the three binding glycolipids is a terminal Gal alpha 1----4Gal disaccharide linked beta 1----4 to either Glc or GlcNAc. Globoisotriaosylceramide, which differs from Gb3 only in possessing a Gal alpha 1----3Gal terminal disaccharide, and LacCer, which lacks the terminal Gal residue of Gb3, were incapable of binding the toxin. Binding was shown to be mediated by the B subunit by the use of isolated toxin A and B subunits and monoclonal subunit-specific antibodies. Gb3-containing liposomes competitively inhibited the binding of toxin to HeLa cell monolayers but did not inhibit toxin-induced cytotoxicity. These studies show an identical carbohydrate-specific glycolipid receptor for shigella toxin in gut and in HeLa cells. The toxin B subunit that mediates this binding has also been shown to recognize a glycoprotein receptor with different sugar specificity. Thus, we have demonstrated that the same small (Mr 6,500) B subunit polypeptide has two distinctive carbohydrate-specific binding sites. The Gal alpha 1----4Gal disaccharide of the glycolipid toxin receptor is also recognized by the Gal-Gal pilus of uropathogenic E. coli. This suggests the possibility that the pilus and toxin B subunit contain homologous sequences. If this is true, it may be possible to use the purified Gal-Gal pilus to produce toxin-neutralizing antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254
Quantitative isolation of total glycosphingolipids from animal cells
Saito, T., & Hakomori, S.-I. (1971) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39537-7 · Cited by 550
THE PkANTIGEN AS RECEPTOR FOR THE HAEMAGGLUTININ OF PYELONEPHRITIC ESCHERICHIA COLI
KÃLLENIUS, G., MÃLLBY, R., SVENSON, S. B., WINBERG, J., LUNDBLAD, A., SVENSSON, S., & CEDERGREN, B. (1980) · FEMS Microbiology Letters · doi:10.1111/j.1574-6941.1980.tb01608.x · Cited by 390
Gangliosides of human, bovine, and rabbit plasma
Yu, R. K., & Ledeen, R. W. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39374-3 · Cited by 352
Leffler, H., & Svanborg-Edén, C. (1981) · Infection and Immunity · doi:10.1128/iai.34.3.920-929.1981 · Cited by 315
Bock, K., Breimer, M. E., Brignole, A., Hansson, G. C., Karlsson, K. A., Larson, G., Leffler, H., Samuelsson, B. E., Strömberg, N., & Edén, C. S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39507-8 · Cited by 293
ISOLATION OF BRAIN STRANDIN, A NEW TYPE OF LARGE MOLECULE TISSUE COMPONENT
Folch, J., Arsove, S., & Meath, J. A. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55986-x · Cited by 287
Fukushi, Y., Hakomori, S., Nudelman, E., & Cochran, N. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43100-0 · Cited by 231
Self-citationO'Hanley, P., Lark, D., Falkow, S., & Schoolnik, G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111707 · Cited by 224
Donohue‐Rolfe, A., Keusch, G. T., Edson, C. M., et al. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.160.6.1767 · Cited by 184
Self-citation
Cited by
Infection by verocytotoxin-producing Escherichia coli
Karmali, M. A. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.1.15 · Cited by 1,322
Virulence factors in Escherichia coli urinary tract infection
Johnson, J. R. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.1.80 · Cited by 1,290
O’Brien, A. D., & Holmes, R. K. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.2.206-220.1987 · Cited by 727
Shiga toxins — from cell biology to biomedical applications
Johannes, L., & Römer, W. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2279 · Cited by 509
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion
Sears, C. L., & Kaper, J. B. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.1.167-215.1996 · Cited by 508
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
Lingwood, C. A., Law, H., Richardson, S., Petric, M., Brunton, J. L., De Grandis, S., & Karmali, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47490-x · Cited by 463
Structure of the Shiga-like Toxin I B-Pentamer Complexed with an Analogue of Its Receptor Gb3,
Ling, H., Boodhoo, A., Hazes, B., Cummings, M. D., Armstrong, G. D., Brunton, J. L., & Read, R. J. (1998) · Biochemistry · doi:10.1021/bi971806n · Cited by 438
Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis
O’brien, A. D., Tesh, V. L., Donohue-Rolfe, A., Jackson, M. P., Olsnes, S., Sandvig, K., Lindberg, A. A., & Keusch, G. T. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-77238-2_4 · Cited by 410
Self-citationComparison of the relative toxicities of Shiga-like toxins type I and type II for mice
Tesh, V. L., Burris, J. A., Owens, J. W., Gordon, V. M., Wadolkowski, E. A., O'Brien, A. D., & Samuel, J. E. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3392-3402.1993 · Cited by 392
Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution
Fraser, M. E., Chernaia, M. M., Kozlov, Y. V., & James, M. N. G. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0194-59 · Cited by 299
Glycosphingolipids: synthesis and functions
D'Angelo, G., Capasso, S., Sticco, L., & Russo, D. (2013) · FEBS Journal · doi:10.1111/febs.12559 · Cited by 298
Endothelial heterogeneity in Shiga toxin receptors and responses
Obrig, T. G., Louise, C. B., Lingwood, C. A., Boyd, B., Barley-Maloney, L., & Daniel, T. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82282-7 · Cited by 295
Lund, B., Lindberg, F., Marklund, B. I., & Normark, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5898 · Cited by 294
Inhibition of Retrograde Transport Protects Mice from Lethal Ricin Challenge
Stechmann, B., Bai, S.-K., Gobbo, E., Lopez, R., Merer, G., Pinchard, S., Panigai, L., Tenza, D., Raposo, G., Beaumelle, B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.043 · Cited by 290
Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli
Stein, P. E., Boodhoo, A., Tyrrell, G. J., Brunton, J. L., & Read, R. J. (1992) · Nature · doi:10.1038/355748a0 · Cited by 289
Structure, organization, and function of glycosphingolipids in membrane
Hakomori, S. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00004 · Cited by 283
Role of verotoxin receptors in pathogenesis
LINGWOOD, C. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10017-2 · Cited by 267
Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells
WATSON, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.003 · Cited by 265
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.
Calderwood, S. B., Auclair, F., Donohue-Rolfe, A., Keusch, G. T., & Mekalanos, J. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4364 · Cited by 255
Self-citationSandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W., & van Deurs, B. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1331 · Cited by 252
“There is now good evidence from several laboratories that Shiga toxin binds to glycolipids in a specific manner (3, 16, 18, 19, 23).”
BackgroundSphingolipids control dermal fibroblast heterogeneity
Capolupo, L., Khven, I., Lederer, A. R., Mazzeo, L., Glousker, G., Ho, S., Russo, F., Montoya, J. P., Bhandari, D. R., Bowman, A. P., et al. (2022) · Science · doi:10.1126/science.abh1623 · Cited by 197
“This is a bistable system in which cells can be Gb3+ or Gb4+, leading to a more fibrolytic state, or GM1+, leading to a more fibrogenic state. p-Lenti Gb4S-V5-OE GM3S-V5-OE A C TA 2 M M P 1 -3 0 3 Lo g 2 F C MMP1 ACTA2 ** * * * FB1 FB1 FB1 E DB C -2 0 2 Lo g 2 F C CTRL FB1 CTRL FB1 CTRL FB1 pLenti DNTGFR2 DNFGFR1 T G…”
BackgroundInfluentialSandvig, K., Ryd, M., Garred, O., Schweda, E., Holm, P. K., & van Deurs, B. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.53 · Cited by 179
“Purification and Characterization of Shiga Toxin Receptors Since butyric acid-induced retrograde transport could be demonstrated only for Shiga toxin which binds to neutral glycosphingolipids with the sequence galcd-4galB (9, 21 , 32), we decided to analyze whether butyric acid treatment caused any changes in the comp…”
BackgroundPark, J., Kim, K. S., Lee, S., Ryu, J., Chung, K. C., Choo, Y., Jou, I., Kim, J., & Park, S. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06150.x · Cited by 135
Rizzo, R., Russo, D., Kurokawa, K., Sahu, P., Lombardi, B., Supino, D., Zhukovsky, M. A., Vocat, A., Pothukuchi, P., Kunnathully, V., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020107238 · Cited by 101
“As shown in Fig 1F, we observed an increase in the levels of the globo series GSLs Gb3 [as assessed by Shiga toxin (ShTxB) (Jacewicz et al, 1986)] in GOLPH3 OE.”
Self-citationHuffman, D. L., Bischof, L. J., Griffitts, J. S., & Aroian, R. V. (2004) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00303 · Cited by 55
Metadata
- Authors
- Jacewicz, M., Clausen, H., Nudelman, E., Donohue-Rolfe, A., & Keusch, G. T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1986-06-01
- Volume
- 163
- Issue
- 6
- Pages
- 1391-1404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2074484003
- Cited by
- 405
- References
- 17
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.